Drugs / WAL2014
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02264080 | Mar 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WAL2014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02264080 ↗ |
| Route | Oral | “WAL2014 capsules administered orally” NCT02264080 ↗ |